Abstract:Stress response and depression have a crucial impact on modern society. Although the symptoms are well characterized, the molecular mechanisms underlying depression are largely unknown. Currently, the monoaminergic systems, especially serotonergic systems, have received the most attention in the research of depression. Accumulating evidence suggests that the glutamatergic and GABAergic system play an important role in the neurobiology and treatment of this disease. Multiple studies have shown that serotonin (5-HT) could modulate the neurotransmission of glutamic acid (Glu) and gamma-aminobutyric acid (GABA). The orbitofrontal cortex (OFC), which is involved in the pathophysiology and treatment of depression, plays a critical role in the control of higher brain functions and it mainly receives a dense 5-HT innervation from the dorsal raphe nucleus. There exist some 5-HT1A receptors on glutamatergic neurons and GABAergic neurons in the OFC. The purpose of this research was to elucidate the modulatory action of 5-HT1A receptor on the functions of Glu and GABA, which are the principal neurotransmitters mediating excitatory and inhibitory signals in the OFC respectively, in a well-established animal model of depression induced by chronic unpredictable mild stress (CUMS). We used CUMS in rat to mimic the core symptoms in human. Using the pharmacology approaches by microinjecting of 5-HT1A receptor agonist 8-OH-DPAT and its antagonist WAY100635 to the OFC, we detected behavioral changes by using behavior tests including sucrose preference test, open field test and tail suspension test. In addition, high-performance liquid chromatography (HPLC) was used to detect the level of neurotransmitters such as 5-HT, Glu and GABA in the OFC, respectively. CUMS group showed a variety of behavioral characteristics of depression, including a significant reduction in the sucrose preference, and locomotion, rearing and grooming in the open field test, and a significant increase in immobility time in the tail suspension test compared with control group. In addition, CUMS group showed that a significant increase in the concentration of Glu, but no significant difference in the levels of 5-HT and GABA in the OFC. Depression-like behaviors of CUMS rats were obviously ameliorated after being treated with 8-OH-DPAT, while the concentration of Glu was decreased. Rats received WAY100635 in control group showed similar depression-like behaviors and similar increased Glu levels. However, 5-HT level and GABA concentration were not altered in both groups received 8-OH-DPAT or WAY100635. These findings indicated that the mechanism through which CUMS could induce depression-like behaviors, probably is not due to the decrease of 5-HT level within the OFC, but because of excessive release of Glu that resulted from that 5-HT could not regulate glutamatergic neurons or the decrease of 5-HT1A receptor function on glutamatergic neurons within the OFC during stress. Our data suggested that 5-HT1A receptor in the OFC plays an important role in modulating the synthesis and release of Glu during CUMS. This study provided insights on modulation of glutamate transmission in depression.

Glutamate Transporter 1-Mediated Antidepressant-Like Effect in a Rat Model of Chronic Unpredictable Stress

Microglial glutaminase 1 mediates chronic restraint stress-induced depression-like behaviors and synaptic damages

Effects of fluoxetine on changes of GLT-1 in rat prefrontal cortex after chronic unpredictable stress

Mir-16 and Fluoxetine Both Reverse Autophagic and Apoptotic Change in Chronic Unpredictable Mild Stress Model Rats.

Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole

Effects of Ceftriaxone on Depressive-Like Behavior and Changes of Hippocampal Glutamate Transporter-1 in Depression Model C57 Mice

Deficiency of astrocyte CysLT 1 R ameliorates depression-like behaviors in mice by modulating glutamate synaptic transmission

Glutamate Chemical Exchange Saturation Transfer Imaging and Functional Alterations of Hippocampus in Rat Depression Model: A Pilot Study

High-frequency repetitive transcranial magnetic stimulation improves depressive-like behaviors in CUMS-induced rats by modulating astrocyte GLT-1 to reduce glutamate toxicity

VGLUT2 may improve cognitive function in depressed rats by protecting prefrontal cortex neurons

RAGE Signaling pathway in hippocampus dentate gyrus involved in GLT-1 decrease induced by chronic unpredictable stress in rats

The Impact of Repetitive Transcranial Magnetic Stimulation and Fluoxetine on the Brain Lipidome in a Rat Model of Chronic Unpredictable Stress

Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression.

Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression.

Effects of Fluoxetine on gut Microbiota in Chronic Unpredictable Stress-Induced Depressive-Like Rats

Hypothalamic Gastrin-Releasing Peptide Receptor Mediates an Antidepressant-Like Effect in a Mouse Model of Stress.

Neurotransmitter and Related Metabolic Profiling in the Nucleus Accumbens of Chronic Unpredictable Mild Stress-Induced Anhedonia-Like Rats

Orbitofrontal Cortex 5-HT1A Receptor Modulate Glutamate and GABA in Depression Induced by Chronic Unpredictable Mild Stress

Alteration in NMDAR subunits in different brain regions of chronic unpredictable mild stress (CUMS) rat model

Chronic Unexpected Mild Stress Destroys Synaptic Plasticity of Neurons Through a Glutamate Transporter, GLT-1, of Astrocytes in the Ischemic Stroke Rat

Involvement of Chronic Unpredictable Mild Stress-Induced Hippocampal LRP1 Up-Regulation in Microtubule Instability and Depressive-Like Behavior in a Depressive-Like Adult Male Rat Model.